Kim Hye-Jin, Shin Sang-Wook, Park Seyeon, Kim Hee Young
Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.
Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine, Yangsan, Korea.
J Chest Surg. 2022 Aug 5;55(4):293-300. doi: 10.5090/jcs.22.046.
Lung transplantation is the only treatment option for patients with end-stage lung disease. Although more than 4,000 lung transplants are performed every year worldwide, the standardized protocols contain no guidelines for monitoring during lung transplantation. Specific anesthetic concerns are associated with lung transplantation, especially during critical periods, including anesthesia induction, the initiation of positive pressure ventilation, the establishment and maintenance of one-lung ventilation, pulmonary artery clamping, pulmonary artery unclamping, and reperfusion of the transplanted lung. Anesthetic management according to the special risks associated with a patient's existing lung disease and surgical stage is the most important factor. Successful anesthesia in lung transplantation can improve hemodynamic stability, oxygenation, ventilation, and outcomes. Therefore, anesthesiologists must have expertise in transesophageal echocardiography, extracorporeal life support, and cardiopulmonary anesthesia and understand the pathophysiology of end-stage lung disease and the drugs administered. In addition, communication among anesthesiologists, surgeons, and perfusionists during surgery is important to achieve optimal patient results.
肺移植是终末期肺病患者唯一的治疗选择。尽管全球每年进行超过4000例肺移植手术,但标准化方案中没有关于肺移植期间监测的指南。肺移植存在特定的麻醉问题,尤其是在关键时期,包括麻醉诱导、开始正压通气、建立和维持单肺通气、肺动脉钳夹、肺动脉松开以及移植肺再灌注。根据患者现有肺部疾病和手术阶段相关的特殊风险进行麻醉管理是最重要的因素。肺移植手术中成功的麻醉可以改善血流动力学稳定性、氧合、通气和预后。因此,麻醉医生必须具备经食管超声心动图、体外生命支持和心肺麻醉方面的专业知识,并了解终末期肺病的病理生理学以及所使用的药物。此外,手术期间麻醉医生、外科医生和灌注师之间的沟通对于实现最佳患者治疗效果很重要。